Diligence memo · auto-generated · as of July 3, 2026

Medical Innovation Centers of America, Inc.

Medical Innovation Centers of America, Inc. looks fair against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Medical Innovation Centers of America, Inc. operates in Healthtech, based in BROKEN ARROW.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Medical Innovation Centers of America, Inc. has raised $625K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $500K on 2023-09-11.

Most recent recorded round closed around 2023-09-11.

Valuation (modeled)modeled

Provath models Medical Innovation Centers of America, Inc. at approximately $3.3M (range $313K–$14M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.19× the median modeled value of Pre-Seed Healthtech companies in 2022–2024 (174 peers) — value vs value, same stage and era. Within the normal band (119% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 1 months.

Last raise 2.8 yr ago; this sector typically re-raises about every 14 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 4.0× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 23% of Healthtech peers (2138 compared).

Modeled value ranks above 18% of those peers.

Closest niche peers: Hoy Health Corp, Ennova Health LLC, Telebelly Health, Inc., Health Rosetta Group PBC, B2M Medical, Inc..

Peoplefiled

2 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.